Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 03/02/16

Office of the Associate Director (OAD)

DTP provides resources and services to both public and private research communities, maintains a robust infrastructure for anti-cancer drug discovery and development, and manages a large portfolio of grants pertinent to drug discovery and biochemical pharmacology. Upon request, DTP also provides advices on drug development issues regarding chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.

DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.

OAD Staff:

Name Position Email
Dr. Jerry M. Collins Associate Director collinsje@mail.nih.gov
Dr. Min He Special Assistant to DTP Associate Director hem3@mail.nih.gov
Dr. Brian D. Peyser Special Assistant to DTP Associate Director brian.peyser@nih.gov
Dr. Michael Currens Special Assistant to DTP Associate Director currens@mail.nih.gov
Bernadette Carter Program Assistant carterb2@mail.nih.gov

About the
Associate Director

Jerry M. Collins, Ph.D. Jerry M. Collins, Ph.D., is an internationally recognized pharmacologist. He has been closely associated with NCI’s drug development efforts for more than 25 years, first as an NCI intramural investigator and then as the Chief of the Pharmacokinetics Section. More…